HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kupferschmid, J. P. Articles by Clark, R. E. Search for Related Content PubMed PubMed Citation Articles by Kupferschmid, J. P. Articles by Clark, R. E.

The Annals of Thoracic Surgery, Vol 48, 359-364, Copyright © 1989 by The Society of Thoracic Surgeons

ARTICLES

Amiodarone-induced complications after cardiac operation for obstructive hypertrophic cardiomyopathy

JP Kupferschmid, TK Rosengart, CL McIntosh, MB Leon and RE Clark
Surgery Branch, NHLBI, Bethesda, MD 20892.

The occurrence of unanticipated and seemingly unexplicable major complications of hepatic, pulmonary, and cardiac dysfunction after palliative operation for obstructive hypertrophic cardiomyopathy prompted a review of 71 sequential patients. Fifty-five patients had been treated preoperatively with beta-blockers, calcium-channel inhibitors, or both, and 16 had received amiodarone for six to 566 days (mean time, 210 days) at total doses ranging from 8 to 175 g (mean dose, 82 g) and had drug-free intervals prior to operation of zero to 457 days (mean time, 91 days). Comparisons were made between the two treatment groups and between those with and without major complications within the amiodarone-treated group. Preoperative cardiac studies, sex, age, functional class, and type of operation were not related to outcome for the entire patient cohort. In amiodarone-treated patients, the major findings were as follows: a 50% incidence of hepatic dysfunction with a tenfold increase in concentrations of serum glutamic- oxaloacetic transaminase and serum glutamic-pyruvic transaminase; a 25% incidence of pulmonary dysfunction necessitating a fourfold increase in the number of days of ventilator support; and a 19% incidence of low cardiac output syndrome with two deaths. Only 44% of the amiodarone- treated group had no serious complications. The incidence of major complications of the liver, lungs, and heart was 2%, 0%, and 2%, respectively, in patients not treated with amiodarone. Abnormal preoperative pulmonary function studies were predictive of prolonged postoperative ventilatory support. Discontinuation of amiodarone for several months prior to operation appeared to reduce the incidence of major complications. The necessary drug-free interval required preoperatively could not be determined from this retrospective experience.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. H. Levy, K. A. Tanaka, and J. M. Bailey Cardiac Surgical Pharmacology Card. Surg. Adult, January 1, 2008; 3(2008): 77 - 110. [Full Text]

				E. Crystal, S. Kahn, R. Roberts, K. Thorpe, M. Gent, J. A. Cairns, P. Dorian, and S. J. Connolly Long-term amiodarone therapy and the risk of complications after cardiac surgery: Results from the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial (CAMIAT) J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 633 - 637. [Abstract] [Full Text] [PDF]

				J. M. Bailey, K. A. Tanaka, and J. H. Levy Cardiac Surgical Pharmacology Card. Surg. Adult, January 1, 2003; 2(2003): 85 - 118. [Full Text]

				S. Kaushik, A. Hussain, P. Clarke, and H. L. Lazar Acute pulmonary toxicity after low-dose amiodarone therapy Ann. Thorac. Surg., November 1, 2001; 72(5): 1760 - 1761. [Abstract] [Full Text] [PDF]

				S. J. Connolly Evidence-Based Analysis of Amiodarone Efficacy and Safety Circulation, November 9, 1999; 100(19): 2025 - 2034. [Full Text] [PDF]

				I. Dimopoulou, K. Marathias, M. Daganou, S. Prapas, G. Stavridis, M. Khoury, S. Geroulanos, and D. V. Cokkinos LOW-DOSE AMIODARONE-RELATED COMPLICATIONS AFTER CARDIAC OPERATIONS J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 31 - 37. [Abstract] [Full Text]

				B. Heric, B. W. Lytle, D. P. Miller, E. R. Rosenkranz, H. M. Lever, and D. M. Cosgrove Surgical management of hypertrophic obstructive cardiomyopathy:Early and late results J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 195 - 208. [Abstract] [Full Text]